Market Update: Eli Lilly & Company (NYSE:LLY) – Lilly’s Humalog® 200 units/mL KwikPen® Now Available in U.S. Pharmacies

[PR Newswire] – U-200), the first and only concentrated mealtime insulin analog in the U.S., is now available in pharmacies, Eli Lilly and Company (LLY) announced today. Humalog U-200 KwikPen is a prefilled . . . → Read More: Market Update: Eli Lilly & Company (NYSE:LLY) – Lilly’s Humalog® 200 units/mL KwikPen® Now Available in U.S. Pharmacies Similar Articles: Stock Update: Eli Lilly & Company (NYSE:LLY) – U.S. Food and Drug Administration Approves Humalog® 200 units/mL KwikPen® Stock Update: Eli Lilly & Company (NYSE:LLY) – Lilly Declares Second-Quarter 2015 Dividend Company Update (NYSE:LLY): Lilly delays submission to market once-daily diabetes drug
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.